Original language | English (US) |
---|---|
Pages (from-to) | 1312-1314 |
Number of pages | 3 |
Journal | The Lancet |
Volume | 382 |
Issue number | 9901 |
DOIs |
|
State | Published - 2013 |
Bibliographical note
Funding Information:ATH receives research funding from AstraZeneca and Pluristem and has consulted for Merck, Novartis, and Anges. SD declares that she has no conflicts of interest.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.